Brind.

Merck (known as MSD outside the US) operates in Canada, where a drug was approved, involving Gynecologic Oncologist Shannon Salvador.

2 reports, 2 independent Updated Aug 5

Gone quiet

Reports: 2
Developments: 2
Repetition: 0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Merck (known as MSD outside the US) operates in Canada, where a drug was approved, involving Gynecologic Oncologist Shannon Salvador.

Who's involved

What this event is mainly about

MSD Merck Shannon Salvador

How it developed

Newest first. Tap a step to see who reported it.

Aug 5Health Canada grants approval for a Merck cancer drug.1 source
- finanznachrichten.de
Jul 21Merck drug approved in Canada; involves Gynecologic Oncologist Shannon Salvador.1 source
- CNW Group

Keep exploring

The entities involved

MSD
company in Rome, Italy
- MSD, which operates as Merck & Co. in the US and Canada, has appointed Vidhya as Associate Vice President.Mon 12:02
- MSD and Aurobindo Pharma signed a voluntary licensing agreement for generic alimatravir.Mon 05:30
Merck
public company in Indonesia
- Eli Lilly, Novo Nordisk, and Merck are currently competing in the highly competitive GLP-1 obesity market.Sat 17:22
- Merck will share clinical trial results at the American Academy of Ophthalmology (AAO) meeting.Fri 18:13
Shannon Salvador
researcher, ORCID id # 0000-0002-8061-375X

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 5finanznachrichten.de
Jul 21CNW GroupHealth Canada Approves KEYTRUDA® for the treatment of adult patients with FIGO 2014 Stage III-IVA cervical cancer, in combination with chemoradiotherapy (CRT)¹ Approval is based on the results from p